Table 3.
Gene Expression Fold Change in MAECs |
|||||||
---|---|---|---|---|---|---|---|
Human Gene | Mouse Gene | MHC Class | From rs3869109, bp | Prelesioned | oxPAPC | oxLDL | Wild-Type Age |
HLA-B | H2-D1 | I | 137 453 | −2.29** | −2.02* | … | … |
HLA-DRA | H2-Ea | II | 1 223 423 | 442^ | … | … | … |
HLA-DQA1 | H2-Aa | II | 1 420 987 | −5.60** | … | … | … |
HLA-DQB1 | H2-Ab1 | II | 1 443 045 | −10.20* | … | −2.71* | −1.95* |
The human homologs of differentially expressed mouse genes are listed, along with their MHC class, distance from the previously published SNP associated with CAD in Genome Wide Association Study (GWAS) meta-analysis, and fold changes of the transcript in MAECs from prelesion aortas, oxPAPC-, or oxLDL-treated aortas, and 24-week BL6 wild-type aortas compared with 4-week endothelium. CAD indicates coronary artery disease; MAEC, mouse aortic endothelial cell; MHC, major histocompatibility complex; oxLDL, oxidized low-density lipoprotein; oxPAPC, 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine; and RT-qPCR, reverse transcription quantitative polymerase chain reaction.
P ≤0.05;
P≤0.01; and
extreme differential expression from very low expression at base level.